Supervision of normal first pregnancy for prevention of preeclampsia. Supervision of normal first pregnancy
Conditions
Interventions
Intervention 1: Intervention group: Garlic tablet, 400 milligram, oral, every 12 hours 1 tablet for 16 weeks. Intervention 2: Control group: Placebo, oral, quite similar to garlic tablet, every 12 hou
Prevention
Intervention group: Garlic tablet, 400 milligram, oral, every 12 hours 1 tablet for 16 weeks
Control group: Placebo, oral, quite similar to garlic tablet, every 12 hours 1 tablet for 16 weeks
Sponsors
Vice Chancellor Of Research of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Having ultrasound based on singleton pregnancy and baby health, 20 weeks pregnancy (according to gestational age in the early pregnancy ultrasound), pregnant women 18-35 years, failure to alcohol and tobacco, having at least read and write, having telephone number for follow-up Exclusion criteria: Systemic diseases such as diabetes mellitus, heart disease, kidney and... according to pregnant women statement, history of clotting disorders, history of hypertension disorder before pregnancy and during current pregnancy, body mass index equal to or greater than 30 kilograms per square meter, systolic blood pressure lower than 100 mmhg, history of allergy to garlic according to pregnant women statement, intake garlic more than 1 serving a day or more than 10 serving per week, participate in other similar studies.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma nitric oxide level. Timepoint: 12 weeks after intervention. Method of measurement: Nitric oxide kit.;The frequency of preeclampsia incidence. Timepoint: Before intervention, 6-10,11-14, 15-17 and 18-20 weeks after intervention. Method of measurement: The blood pressure according to millimeter of mercury using a mercury sphygmomanometer and random urine albumin using diagnostic strips for urine protein assay. | — |
Secondary
| Measure | Time frame |
|---|---|
| The frequency of side events incidence. Timepoint: 8 and 16 weeks after intervention. Method of measurement: The side events check list.;Neonatal anthropometric indexes. Timepoint: After the termination of pregnancy. Method of measurement: Growth monitoring card.;The frequency of preterm delivery incidence. Timepoint: During 16 weeks after intervention. Method of measurement: The folder summary sheet in Health centers.;The patients satisfaction level of received drug. Timepoint: 8 and 16 weeks after intervention. Method of measurement: The check list of satisfaction of received drug. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShafaie Sehhatie Fahimeh
Faculty of Nursing and Midwifery
Outcome results
None listed